INSPInspire Medical Systems, Inc.

$68.91-14% 1Y

Is the business good?

Good

A genuinely good business: earnings fully cash-backed (3.7×) and margins widening.

2 good, 2 neutral
Fundamental health (F-score)6 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash3.67×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years+15.7 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from13% ROA

A balanced mix of margins, efficiency, and leverage. ROE 15% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 67% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is INSP?

Inspire Medical Systems, Inc. earns 8.5% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

8.5%

Return on invested capital · cost of capital 9.0% · 0.53 points below what the capital costs: growth destroys value

Operating margin
6.0%

Operating margin · Medical Devices median 2.1% · 12 months to Q2 2026

Cash conversion
3.67×

Cash conversion · 3.14× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−1.9%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY2020−49%
FY2021−17%
FY2022−12%
FY2023−6.5%
FY20244.5%
FY20255.6%
Details›
Gross margin12 months to Q2 2026
86%
Operating margin12 months to Q2 2026
6.0%
Net margin12 months to Q2 2026
15%
Free cash flow margin
13%
R&D as % of revenue
11%
Revenue, trailing twelve months
$899M
Free cash flow, trailing twelve months
$117M
Net income, trailing twelve months
$135M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
8.5%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.